openPR Logo
Press release

Growth in Adoption of Pertussis Vaccination and Government Insurance are Projected to Drive the Pertussis Vaccine Market Globally

07-14-2017 12:49 PM CET | Health & Medicine

Press release from: Transparency Market Research

Growth in Adoption of Pertussis Vaccination and Government

Pertussis vaccine is used for whooping cough. This vaccine is available only in combination with other vaccines. Pertussis vaccination is recommended for all children, babies, teens, and pregnant women. Diphtheria, tetanus, and pertussis (DTaP) vaccines are given to children younger than seven years old, while tetanus, diphtheria, and pertussis (Tdap) vaccines are given to older children and adults. Childhood vaccination is one of the safest and cost-effective ways for pertussis-free environment. The World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) recommend all children should be routinely vaccinated for pertussis.

According to WHO in 2015, about 86% of infants received three doses of diphtheria-tetanus-pertussis (DTP3) vaccine worldwide to protect them against infectious diseases. In 2015, procurement of DTwP vaccine through UNICEF had reached 5.8 million doses for 18 countries and territories out of which four countries such as Egypt, Morocco, Uzbekistan, and Zimbabwe accounted for more than 80% of UNICEF’s total procurement.

Browse Market Research Report @ http://www.transparencymarketresearch.com/pertussis-vaccine-market.html

Factors such as high birth rate, increase in number of geriatric population, government initiatives, growth in adoption of pertussis vaccination, and government insurance and reimbursement scenario are projected to drive the pertussis vaccine market globally. According to WHO in 2015, 126 countries had reached at least 90% coverage of diphtheria-tetanus-pertussis vaccine. On the other hand, factors such as vaccine injuries and adverse event are expected to hinder the growth of the pertussis vaccine market globally. In the U.S. in 2015, there had been 7 claims filed in the federal Vaccine Injury Compensation Program (VICP) for injuries and deaths following pertussis vaccination, including three deaths and four serious injuries.

The pertussis vaccine market has been segmented by product type, vaccine type, age group, end-user, and geography. In terms of product type, the pertussis vaccine market is classified into DTaP vaccine and Tdap vaccine. The DTaP vaccine segment includes products such as Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, and Quaracel. The Tdap vaccine segment comprises products such as Boostrix and Adacel. In terms of vaccine type, the pertussis vaccine market is classified into whole-cell vaccine and acellular vaccine.

The acellular vaccine segment is highly used owing to less side effect. The acellular vaccine is about 71%–85% effective, whereas whole-cell vaccine is about 78% effective. In terms of age group, the pertussis vaccine market is classified into adult and pediatric. In terms of end-user, the market is classified into hospitals, clinics, and vaccination centers. Geographically, the pertussis vaccine market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

North America dominates the pertussis vaccine market due to growth in number of geriatric population and increase in pertussis death rate in the U.S, which drive the pertussis vaccine market. In 2014, according to the CDC, 28,660 cases of pertussis were reported in the U.S. The North America market is followed by the Europe and Asia Pacific markets. Asia Pacific is expected to grow at a higher rate due to rapid population growth, increase in adoption for vaccination, and growth in prevalence of infectious disease. These factors are expected to fuel the pertussis vaccine market.

For more information on this report, fill the form @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=18884

In the Asia Pacific region, Thailand accounts for 99% in pertussis vaccine coverage, followed by Japan and China with 98% and 97%, respectively. Developing countries such as Brazil, South Africa, and Mexico are estimated to create good opportunity for the pertussis vaccine market growth attributing to rise in number of government and private health care insurance coverage, increase in health care expenditure, and growth in awareness among people.

Major players operating in this market include Sanofi Pasteur, GlaxoSmithKline, Protein Sciences Corporation, Novartis AG, Seqirus, Merck Sharp & Dohme Corp., and Astellas Pharma US, Inc.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Growth in Adoption of Pertussis Vaccination and Government Insurance are Projected to Drive the Pertussis Vaccine Market Globally here

News-ID: 625294 • Views:

More Releases from Transparency Market Research

Dried Potatoes Market to Reach USD 3368.4 Million by 2027, Driven by Convenience Food Demand
Dried Potatoes Market to Reach USD 3368.4 Million by 2027, Driven by Convenience …
The global dried potatoes market is poised for significant growth, with projections indicating a market value of USD 3368.4 million by the end of 2027, reflecting a compound annual growth rate (CAGR) of 3.5% over the forecast period. Volume production is expected to reach 9,675,519 metric tons (MT) by 2027, driven by the rising demand for convenience foods, the expanding food processing industry, and the increasing consumption of processed potatoes. 𝐆𝐞𝐭
Coconut Milk Market to Achieve 6.9% CAGR, Reaching 752,551 MT in Production by 2026
Coconut Milk Market to Achieve 6.9% CAGR, Reaching 752,551 MT in Production by 2 …
The global market for coconut milk products is projected to achieve remarkable growth, with an anticipated market value of US$ 1,508.7 million by the end of 2026. This robust expansion, expected at a Compound Annual Growth Rate (CAGR) of 6.9% during the forecast period, highlights the increasing consumer preference for plant-based alternatives and the rising popularity of Asian cuisines globally. 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=56040 Coconut milk
Dry Natural Gas Market Expected to Reach USD 1.6 Trillion by 2031 with 7.1% CAGR Growth
Dry Natural Gas Market Expected to Reach USD 1.6 Trillion by 2031 with 7.1% CAGR …
The dry natural gas market is poised for significant growth, driven by increasing energy demand, environmental regulations favoring cleaner fuels, and advancements in gas extraction and transportation technologies. The global market, valued at US$ 841.7 billion in 2021, is estimated to grow at a robust compound annual growth rate (CAGR) of 7.1% from 2022 to 2031, reaching US$ 1.6 trillion by the end of 2031. Market Overview: Dry natural gas, composed primarily
Sustainable Marine Fuel Market Projected to Reach USD 218.1 Billion by 2031 with 50.2% CAGR Growth
Sustainable Marine Fuel Market Projected to Reach USD 218.1 Billion by 2031 with …
The sustainable marine fuel market is poised for substantial growth, driven by increasing environmental regulations, a growing focus on decarbonization, and rising demand for cleaner energy sources in the maritime industry. The global industry, valued at US$ 3.8 billion in 2021, is estimated to advance at a remarkable compound annual growth rate (CAGR) of 50.2% from 2022 to 2031, reaching US$ 218.1 billion by the end of 2031. Market Overview: Sustainable marine

All 5 Releases


More Releases for Pertussis

Diphtheria, Pertussis, and Tetanus Vaccine Market
According to a new report published by Allied Market Research, titled, "Diphtheria, Pertussis, and Tetanus Vaccine Market by Product Type [DTaP (Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, and Quaracel), Td (Decavac and Tenivac), and Tdap (Boostrix and Adacel)], Vaccine Type (Whole-Cell Vaccine and Acellular Vaccine), Age Group (Adult and Pediatric), and End User (Hospitals, Clinics, and Vaccination Centers) - Global Opportunity and Forecast, 2019-2026 ". The Global market size of Diphtheria, Pertussis,
Expanding China Market of Pertussis Vaccine Research report 2018
The report “China Pertussis Vaccine Market by Manufacturers, Regions, Type and Application” highlights key dynamics of Pertussis Vaccine sector. The potentiality of this sector has been examined along with the significant challenges and growth opportunities. The present market scenario and future predictions of the sector has also been studied in-depth in this report. The report also provides the key market players that are assessed on numerous parameters such as manufacturer’s
Global Pertussis Vaccine Consumption 2016 Market Research Report
The Global Pertussis Vaccine Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Pertussis Vaccine market. First, the report provides a basic overview of the Pertussis Vaccine industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report states the global Pertussis Vaccine market size (volume and value),
Pertussis Vaccine Industry 2024 Market Research Report
Pertussis vaccine is used for whooping cough. This vaccine is available only in combination with other vaccines. Pertussis vaccination is recommended for all children, babies, teens, and pregnant women. Diphtheria, tetanus, and pertussis (DTaP) vaccines are given to children younger than seven years old, while tetanus, diphtheria, and pertussis (Tdap) vaccines are given to older children and adults. Childhood vaccination is one of the safest and cost-effective ways for pertussis-free
Pertussis Vaccine Industry 2024 Market Research Report
Pertussis vaccine is used for whooping cough. This vaccine is available only in combination with other vaccines. Pertussis vaccination is recommended for all children, babies, teens, and pregnant women. Diphtheria, tetanus, and pertussis (DTaP) vaccines are given to children younger than seven years old, while tetanus, diphtheria, and pertussis (Tdap) vaccines are given to older children and adults. Childhood vaccination is one of the safest and cost-effective ways for pertussis-free
Pertussis Vaccine Market 2024 Forecast & Future Industry Trends
Pertussis vaccine is used for whooping cough. This vaccine is available only in combination with other vaccines. Pertussis vaccination is recommended for all children, babies, teens, and pregnant women. Diphtheria, tetanus, and pertussis (DTaP) vaccines are given to children younger than seven years old, while tetanus, diphtheria, and pertussis (Tdap) vaccines are given to older children and adults. Childhood vaccination is one of the safest and cost-effective ways for pertussis-free